Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

abcdefghijklmnoprstuvxyz

Filters

Pipeline

Commercial

Therapeutic Category

Alimentary tract & metabolismAntifungal agentAnti-infectives for systemic useAntipyretic, analgesic and anti-inflammatoryAntineoplastic & immunomodulating agentsBlood & blood forming organsCardiovascular systemGenito-urinary system & sex hormonesInjectable FormsMusculo-skeletal systemNervous systemOpthalmological preparationsRespiratory systemOncology

Available EU DMF/CEP/US DMF

Injectable Forms

Reset filters

API product & pipeline (pdf)

Sort by

Alphabetical Therapeutic Category

Sort:

Alphabetical Therapeutic Category

Status

Therapeutic Category

Polymorphic form

CAS No.

    A

  • Apixaban

    StatusPipeline

    Therapeutic CategoryBlood & blood forming organs

    Polymorphic formCrystalline form N-1

    CAS No.503612-47-3

    View more

  • Apremilast

    StatusPipeline

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formForm B

    CAS No.608141-41-9

    View more
    • B

  • Baricitinib

    StatusPipeline

    Therapeutic CategoryAntineoplastic & immunomodulating agents

    Polymorphic formForm I

    CAS No.1187594-09-7

    View more

  • Brexpiprazole

    StatusPipeline

    Therapeutic CategoryNervous system

    Polymorphic formForm I

    CAS No.913611-97-9

    View more
    • D

  • Dapagliflozin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formAmorphous

    CAS No.461432-26-8

    View more

  • Dapagliflozin propanediol monohydrate

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formCrystalline SC-3

    CAS No.960404-48-2

    View more
    • E

  • Empagliflozin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formCrystalline anhydrous

    CAS No.864070-44-0

    View more

  • Enzalutamide

    StatusPipeline

    Therapeutic CategoryOncology

    Polymorphic formAnhydrous form R1

    CAS No.915087-33-1

    View more
    • I

  • Isavuconazonium sulfate

    StatusPipeline

    Therapeutic CategoryAntifungal agent

    Polymorphic formAmorphous

    CAS No.742049-41-8

    View more
    • L

  • Linagliptin

    StatusPipeline

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formMix of form A & B

    CAS No.668270-12-0

    View more
    • P

  • Palbociclib

    StatusPipeline

    Therapeutic CategoryOncology

    Polymorphic formcrystal form A

    CAS No.571190-30-2

    View more

  • Pimavanserin tartrate

    StatusPipeline

    Therapeutic CategoryNervous system

    Polymorphic formCrystalline anhydrous form C

    CAS No.706782-28-7

    View more
    • R

  • Rivaroxaban

    StatusPipeline

    Therapeutic CategoryBlood & blood forming organs

    Polymorphic formModification I

    CAS No.366789-02-8

    View more
    • S

  • Sacubitril/Valsartan Complex

    StatusPipeline

    Therapeutic CategoryCardiovascular system

    Polymorphic formCrystalline

    CAS No.936623-90-4

    View more

  • Safinamide methanesulfonate

    StatusPipeline

    Therapeutic CategoryNervous system

    Polymorphic formCrystalline anhydrous form A1

    CAS No.202825-46-5

    View more
    • T

  • Ticagrelor

    StatusPipeline

    Therapeutic CategoryBlood & blood forming organs

    Polymorphic formForm II

    CAS No.274693-27-5

    View more